Triamcinolone acetonide-d7
Triamcinolone acetonide-d7 is the deuterium labeled Triamcinolone acetonide. Triamcinolone acetonide is a more potent type of triamcinolone, being about 8 times as effective as prednisone.
Product Specifications
UNSPSC
12352005
Target
Glucocorticoid Receptor; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Immunology/Inflammation; Others; Vitamin D Related/Nuclear Receptor
Field of Research
Inflammation/Immunology; Endocrinology; Cancer
Solubility
10 mM in DMSO
Smiles
O=C1C=C[C@]2(C(CC[C@@]3([C@@]2([C@H](C[C@]4([C@]3(C[C@@]5([C@]4(OC(C([2H])([2H])[2H])(O5)C([2H])([2H])[2H])C(C(O)[2H])=O)[H])[H])C)O)F)[H])=C1)C
Molecular Formula
C24H24D7FO6
Molecular Weight
441.54
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]http://en.wikipedia.org/wiki/Triamcinolone_acetonide|[3]Zhen Xiang, et al. Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels. Int J Biol Sci 2020; 16 (13) :2382-2391.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx526152 96 Tests
Mouse GRIP1-associated protein 1 (GRIPAP1) ELISA Kit
Sign In for Pricing
View Details 
GTR15163717 1 Vial
Lentiviral human WFDC10B shRNA (UAS) - Lentiviral human WFDC10B shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
031100-PE 200 µL
MAP Kinase 15 (Mitogen-activated Protein Kinase 15, MAPK 15, MAPK15, Extracellular Signal-regulated Kinase 7, ERK7, ERK-7, Extracellular Signal-regulated Kinase 8, ERK8, ERK-8) (PE) discontinued
Sign In for Pricing
View Details 